The early use of yellow fever virus strain 17D for vaccine production in Brazil - a review
AUTOR(ES)
Post, Paulo Roberto, Carvalho, Ricardo de, Freire, Marcos da Silva, Galler, Ricardo
FONTE
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
2001-08
RESUMO
The use of yellow fever (YF) virus 17D strain for vaccine production adapted in Brazil since its introduction in 1937 was reviewed. This was possible due to the availability of official records of vaccine production. The retrieved data highlight the simultaneous use of several serially passaged 17D substrain viruses for both inocula and vaccine preparation that allowed uninterrupted production. Substitution of these substrain viruses became possible with the experience gained during quality control and human vaccination. Post-vaccinal complications in humans and the failure of some viruses in quality control tests (neurovirulence for monkeys) indicated that variables needed to be reduced during vaccine production, leading to the development of the seed lot system. The 17DD substrain, still used today, was the most frequently used substrain and the most reliable in terms of safety and efficacy. For this reason, it is possible to derive an infectious cDNA clone of this substrain combined with production in cell culture that could be used to direct the expression of heterologous antigens and lead to the development of new live vaccines.
Documentos Relacionados
- Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.
- Is a dose of 17D vaccine in the current context of Yellow Fever enough?
- Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D Vaccine
- Yellow Fever Vaccine. V. Antibody Response in Monkeys Inoculated with Graded Doses of the 17D Vaccine
- The yellow fever 17D vaccine virus as a vector for the expression of foreign proteins: development of new live flavivirus vaccines